CareerContact usPartners

SHRINKING OPTICS.

EXPANDING DIAGNOSIS.

New Technology

Last Inch Assessment™ (LIA™)

Last Inch Assessment™ (LIA™)

Our flagship LIA™ Technology delivers an immediate boost in the efficacy and accuracy of pulmonary imaging and biopsies.

LEARN MORE

PRECISION

OPTICS FOR CANCER DETECTION

BIOPSY

desperately needs innovation

LEARN MORE

MISSION

We are on a mission to to improve patient lives through early lung cancer detection.

PRECISION

OPTICS FOR CANCER DETECTION

BIOPSY

desperately needs innovation

LEARN MORE

MISSION

We are on a mission to to improve patient lives through early lung cancer detection.

PRECISION

OPTICS FOR CANCER DETECTION

BIOPSY

desperately needs innovation

LEARN MORE

MISSION

We are on a mission to to improve patient lives through early lung cancer detection.

PRECISION

OPTICS FOR CANCER DETECTION

BIOPSY

desperately needs innovation

LEARN MORE

MISSION

We are on a mission to to improve patient lives through early lung cancer detection.

Testimonial

Ali Sadoughi, MD
Albert Einstein College of Medicine,Clinical Advisory Board

“Despite significant advancements in interventional pulmonology, confirming the placement of a biopsy needle in small lesions remains challenging. However, I am very optimistic about the early results from LIA and its real-time nodule assessment capabilities. I believe this willsubstantially narrow the knowledge gap.”

George Cheng, MD
UC San Diego School of Medicine,Clinical Advisory Board

“It's an exciting time for Interventional Pulmonology as we embrace LIA's pioneering microstructure imaging technology. This innovation is the key to unlocking unprecedented precision in IP biopsies, enriching our clinical acumen. I'm enthused by the potential of LIA to refine patient care and eager to contribute to the groundbreaking work that willshape the future of our field.”

Kyle Hogarth, MD, FCCP
University of Chicago School of Medicine,Clinical Advisory Board

“Real-time microstructure imaging to guide biopsy has been something missing in IP. LEADOPTIK technology will demonstrate the clinical utility of their product for everyday use in the bronch suite. I am very excited by their approach and the evaluation of quality, cost, and usefulness as they arepreparing for their FDA submission.”

Supported by

PRECISION

OPTICS FOR CANCER DETECTION

BIOPSY

desperately needs innovation

LEARN MORE

MISSION

We are on a mission to to improve patient lives through early lung cancer detection.